Effect of Erythromycin on the absorption, metabolism and elimination of CHF6001 in healthy volunteers
CLI-06001AA1-14
Phase 1 other active
Quick answer
Effect of Erythromycin on the absorption, metabolism and elimination of CHF6001 in healthy volunteers for This study is a phase I trial to investigate the effect of inhibition of CYP3A4/5 by Erythromycin on the pharmacokinetics of CHF6001 in healthy volunteers. is a Phase 1 program (other) at Chiesi Farmaceutici S.p.A with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Chiesi Farmaceutici S.p.A
- Indication
- This study is a phase I trial to investigate the effect of inhibition of CYP3A4/5 by Erythromycin on the pharmacokinetics of CHF6001 in healthy volunteers.
- Phase
- Phase 1
- Modality
- other
- Status
- active